 |
| Thumbs up from Scientific Advisory Panel |
Apollo’s proteins team was given the thumbs up from members of Apollo’s Scientific Advisory Panel at a meeting in Sydney this month for their work on the company’s innovative human cell expressed proteins.
The meeting congratulated the team on its work highlighting the differences and advantages of Apollo’s hcx™ proteins compared to proteins from bacteria, insect and rodent cells produced by other companies. The Panel also identified potential new customers in leading research fields.
“The company is engaging in some unique work that could be very valuable for a broad range of research and clinical applications – very interesting,” said Professor Alan Trounson AO.
“Apollo has accumulated an impressive array of human expressed proteins in a relatively short time. For many research studies, these hcx proteins are likely to prove the reagents of choice.” Professor Peter Schofield
A company’s Scientific Advisory Panel brings a fresh and expert set of eyes to work being done internally. Apollo’s panel is made up of international leaders in their field who together cover a wide area of science. A selection of the Panel meets every six months.
The March meeting reviewed Apollo’s research on its protein portfolio and new molecules being developed. It included members whose work is closest to Apollo’s work on proteins. You can read a brief profile on each in the next article.
Professor Tony Basten AO, who is Chairman of the Scientific Advisory Panel, is in Australia to attend Apollo’s board meeting, from Cambridge University where he is on sabbatical. Professor Alan Trounson AO, who is well known in the field of stem cell research, and is Professor for Stem Cell Sciences at Monash University, flew up from Melbourne for the meeting. Professor Peter Schofield, the director of the Prince of Wales Medical Research Institute, and an adviser to government on stem cell research also attended, together with Professor Nick Hunt, an immunopathologist who heads a major laboratory at Sydney University and Professor Roger Daly from the Garvan.
“Apollo have made excellent progress in developing an innovative portfolio of human cell-expressed reagents that exhibit impressive biological activities. I look forward to testing these in our assays of cancer cell signaling,” commented Prof Roger Daly
Apollo also has ongoing working relationships with the other Scientific Advisory Panel members. Work on oral insulin is ongoing with Professor Zimmet AO, one of the world’s leading diabetes researchers chairman of Apollo’s diabetes advisory board, and Professor Henry Krum from the departments of Epidemiology and Preventive Medicine and Medicine at Monash University. Professor Tony Cunningham, a leading HIV expert and Director of Westmead Hospital's Millennium Institute, is using a custom-made Apollo protein in his studies into how HIV is contracted and absorbed by the body. Professor Andrew Lloyd, from Prince of Wales Hospital and the school of medical sciences at the University of New South Wales is a collaborative partner on Hepatitis C. Professor Simon Sheather, head of the statistics department at Texas A&M University, one of the largest and most prestigious statistics departments in the US, provides ongoing statistical advice and analysis. |
|
|
| click to subscribe |
|
 |
| www.apollolifescience.com |
